Increased Circulating Malondialdehyde-Modified Low-Density Lipoprotein Level Is Associated with High-Risk Plaque in Coronary Computed Tomography Angiography in Patients Receiving Statin Therapy.
Keishi IchikawaToru MiyoshiKazuhiro OsawaTakashi MikiHiroshi ItoPublished in: Journal of clinical medicine (2021)
A high serum MDA-LDL level is an independent predictor of CTA-verified HRP, which can lead to cardiovascular events in statin-treated patients.
Keyphrases
- low density lipoprotein
- coronary artery disease
- cardiovascular events
- cardiovascular disease
- newly diagnosed
- end stage renal disease
- coronary artery
- ejection fraction
- type diabetes
- stem cells
- prognostic factors
- mesenchymal stem cells
- heart failure
- breast cancer cells
- magnetic resonance imaging
- cell proliferation
- patient reported
- atrial fibrillation